Tocilizumab and refractory Takayasu disease: Four case reports and systematic review

Conclusions This review confirms that TCZ is safe and effective in refractory cases of TA and TCZ is a corticosteroid-sparing therapy in patients with or without previous TNFα blockers therapy. However relapses after TCZ discontinuation are frequent.
Source: Autoimmunity Reviews - Category: Allergy & Immunology Source Type: research